Simon Tarsh
Director Financiero/CFO en RENOVARO INC. .
Fortuna: - $ al 30/04/2024
Perfil
Simon Tarsh is currently a Senior Managing Director-Finance Enterprise at Deloitte Consulting LP since 2007.
He is also an Independent Director at Onconetix, Inc. since 2022 and the Chief Financial Officer at Renovaro, Inc. since 2024.
Previously, he served as an Independent Director at Blue Water Biotech, Inc. Mr. Tarsh obtained his undergraduate degree from the University of Salford in 1981 and an MBA from Bayes Business School in 1988.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ONCONETIX INC
-.--% | 05/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
RENOVARO INC.
-.--% | 11/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Simon Tarsh
| Empresas | Cargo | Inicio |
|---|---|---|
| ONCONETIX, INC. | Director/Miembro de la Junta | 01/08/2022 |
| RENOVARO INC. | Director Financiero/CFO | 11/03/2024 |
Deloitte Consulting LP
 Deloitte Consulting LP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LP provides accounting and auditing services. The private company is based in New York, NY. | Corporate Officer/Principal | 01/01/2007 |
Antiguos cargos conocidos de Simon Tarsh.
| Empresas | Cargo | Fin |
|---|---|---|
Blue Water Biotech, Inc.
 Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Director/Miembro de la Junta | - |
Formación de Simon Tarsh.
| University of Salford | Undergraduate Degree |
| Bayes Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RENOVARO INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |
Deloitte Consulting LP
Deloitte Consulting LP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LP provides accounting and auditing services. The private company is based in New York, NY. | Commercial Services |
| Onconetix, Inc. |
- Bolsa de valores
- Insiders
- Simon Tarsh
